(Q73856229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Non-steroidal anti-inflammatory drugs might also be pro-inflammatory by increasing tumor necrosis factor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Kast RE

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

Biomedicine and Pharmacotherapy

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

168-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

Cyclooxygenases as the principal targets for the actions of NSAIDs

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Intracellular signalling mechanisms of interleukin 1 and tumour necrosis factor: possible targets for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Tumor necrosis factor-alpha promotes sustained cyclooxygenase-2 expression: attenuation by dexamethasone and NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Nonsteroidal anti-inflammatory drugs increase tumor necrosis factor production in the periphery but not in the central nervous system in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Increase in tumor necrosis factor-alpha production linked to the toxicity of indomethacin for the rat small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Differential effects of IL-1 beta and ibuprofen after endotoxic challenge in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-alpha ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Prostaglandin, tumor necrosis factor alpha and neutrophils: causative relationship in indomethacin-induced stomach injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

The Heberden Oration 1997. Treatment of rheumatoid arthritis: from symptomatic relief to potential cure.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2989050-2

7 January 2021

10.1016/S0753-3322(00)89050-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10840594%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference